Johns Hopkins Diabetes Guide
Bromocriptine
INDICATIONS
FDA
FDA
- Bromoctriptine quick-release (QR) approved in 2009 for type 2 diabetes mellitus, as an adjunct to diet and exercise
- Other FDA indications include: prolactin-secreting adenomas, hyperprolactinemia, acromegaly, Parkinson’s disease
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Neuroleptic malignant syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 2, 2019
Citation
Crowder, Alona, and Aniket Sidhaye. "Bromocriptine." Johns Hopkins Diabetes Guide, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/all/Bromocriptine.
Crowder A, Sidhaye A. Bromocriptine. Johns Hopkins Diabetes Guide. 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/all/Bromocriptine. Accessed December 5, 2023.
Crowder, A., & Sidhaye, A. (2019). Bromocriptine. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/all/Bromocriptine
Crowder A, Sidhaye A. Bromocriptine [Internet]. In: Johns Hopkins Diabetes Guide. ; 2019. [cited 2023 December 05]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/all/Bromocriptine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bromocriptine
ID - 547171
A1 - Crowder,Alona,PharmD
AU - Sidhaye,Aniket,M.D.
Y1 - 2019/06/02/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/all/Bromocriptine
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
